Nonin Medical has announced a partnership with IDEAL Life, a Toronto-based provider of remote health management solutions. According to a Nonin Medical news release, IDEAL Life will integrate the Nonin Model 3230 Bluetooth Smart wireless pulse oximeter into its latest telehealth platform. The IDEAL system remotely monitors the oxygen saturation and other vital signs of chronic illness patients at home, and then subsequently transmits the data to a clinic or hospital.
The Nonin medical news release notes that the advantages of the Model 3230 include Nonin’s PureSAT pulse oximetry technology, designed to provide precise oximetry measurements; Nonin’s CorrectCheck technology, which provides digital feedback to the user; and Nonin’s SmartPoint capture algorithm that determines when a measurement is ready to be wirelessly transmitted.
Jason Goldberg, president of IDEAL Life, says, “More than ever, the healthcare industry is striving for measurable improvements in societal health and wellness. We focus on keeping healthcare professionals connected to their patients by delivering solutions that leverage high quality products and services.”
The Nonin Model 3230 Bluetooth Smart Pulse Oximeter won the Bluetooth Breakthrough Award in 2014, as noted on the Nonin Medical news release. The Bluetooth Smart wireless technology is designed to provide long battery life and ease of pairing with systems such as the IDEAL Life.
Mark VanderWerf, Vice President of OEM and mHealth for Nonin Medical, states, “Nonin Medical is thrilled to partner with IDEAL Life to help reduce health costs, improve the quality of people’s lives and prevent rehospitalizations. IDEAL Life recognizes that not all pulse oximeters perform alike. Accuracy does matter when remotely monitoring patients with chronic illnesses who need to frequently, easily and reliably measure their blood oxygen saturation levels from home.”
VanderWerf adds, “Unlike health and wellness oximeters, the 3230 is a cleared medical device that provides the accuracy and performance standards required for clinical use.”
Source: Nonin Medical